Market Research

Bipolar Disorder Treatment Market (Type of Treatment: Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), and Others; Type of Bipolar Disorder: Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Diso

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 143 Pages Transparency Market Research Pvt. Ltd. May, 2024 TNPR18955082
Best Price Guarantee
Price from $5,795
Length 143 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date May, 2024
SKU TNPR18955082

Bipolar Disorder Treatment Market (Type of Treatment: Pharmacotherapy, Psychotherapy, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), and Others; Type of Bipolar Disorder: Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Bipolar Disorder Treatment Market – Scope of Report

TMR’s report on the global bipolar disorder treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global bipolar disorder treatment market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bipolar disorder treatment market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the bipolar disorder treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bipolar disorder treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global bipolar disorder treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bipolar disorder treatment market.

The report delves into the competitive landscape of the global bipolar disorder treatment market. Key players operating in the global bipolar disorder treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bipolar disorder treatment market profiled in this report.

Key Questions Answered in Global bipolar disorder treatment Market Report
  • What is the sales/revenue generated by bipolar disorder treatment across all regions during the forecast period?
  • What are the opportunities in the global bipolar disorder treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Bipolar Disorder Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global bipolar disorder treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global bipolar disorder treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bipolar disorder treatment market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bipolar Disorder Treatment Market
4. Market Overview
  4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
  4.2. Overview
  4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
  4.4. Global Bipolar Disorder Treatment Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product/Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Type of Treatment
  6.1. Introduction and Definitions
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Type of Treatment, 2020-2034
6.3.1. Pharmacotherapy
6.3.2. Psychotherapy
6.3.3. Electroconvulsive Therapy (ECT)
6.3.4. Transcranial Magnetic Stimulation (TMS)
6.3.5. Others (Hospitalization, etc.)
  6.4. Market Attractiveness, by Type of Treatment
7. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Drug Class
  7.1. Introduction and Definitions
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Drug Class, 2020-2034
7.3.1. Mood Stabilizers
7.3.2. Antipsychotics
7.3.3. Anti-depressants
7.3.4. Antianxiety Drugs
7.3.5. Others (Anticonvulsants, etc.)
  7.4. Market Attractiveness, by Drug Class
8. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Type of Bipolar Disorder
  8.1. Introduction and Definitions
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
8.3.1. Bipolar I Disorder
8.3.2. Bipolar II Disorder
8.3.3. Cyclothymic Disorder
8.3.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  8.4. Market Attractiveness, by Type of Bipolar Disorder
9. Global Bipolar Disorder Treatment Market Analysis and Forecast, by End-user
  9.1. Introduction and Definitions
  9.2. Key Findings/Developments
  9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Mental Health Centers
9.3.4. Ambulatory Surgical Centers
  9.4. Market Attractiveness, by End-user
10. Global Bipolar Disorder Treatment Market Analysis and Forecast, by Region
  10.1. Key Findings
  10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
  10.3. Market Attractiveness, by Region
11. North America Bipolar Disorder Treatment Market Analysis and Forecast
  11.1. Introduction
11.1.1. Key Findings
  11.2. Market Value Forecast, by Type of Treatment, 2020-2034
11.2.1. Pharmacotherapy
11.2.2. Psychotherapy
11.2.3. Electroconvulsive Therapy (ECT)
11.2.4. Transcranial Magnetic Stimulation (TMS)
11.2.5. Others (Hospitalization, etc.)
  11.3. Market Attractiveness, by Type of Treatment
  11.4. Market Value Forecast, by Drug Class, 2020-2034
11.4.1. Mood Stabilizers
11.4.2. Antipsychotics
11.4.3. Anti-depressants
11.4.4. Antianxiety Drugs
11.4.5. Others (Anticonvulsants, etc.)
  11.5. Market Attractiveness, by Drug Class
  11.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
11.6.1. Bipolar I Disorder
11.6.2. Bipolar II Disorder
11.6.3. Cyclothymic Disorder
11.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  11.7. Market Attractiveness, by Type of Bipolar Disorder
  11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals
11.8.2. Specialty Clinics
11.8.3. Mental Health Centers
11.8.4. Ambulatory Surgical Centers
  11.9. Market Attractiveness, by End-user
  11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
  11.11. Market Attractiveness Analysis
11.11.1. By Type of Treatment
11.11.2. By Drug Class
11.11.3. By Type of Bipolar Disorder
11.11.4. By End-user
11.11.5. By Country
12. Europe Bipolar Disorder Treatment Market Analysis and Forecast
  12.1. Introduction
12.1.1. Key Findings
  12.2. Market Value Forecast, by Type of Treatment, 2020-2034
12.2.1. Pharmacotherapy
12.2.2. Psychotherapy
12.2.3. Electroconvulsive Therapy (ECT)
12.2.4. Transcranial Magnetic Stimulation (TMS)
12.2.5. Others (Hospitalization, etc.)
  12.3. Market Attractiveness, by Type of Treatment
  12.4. Market Value Forecast, by Drug Class, 2020-2034
12.4.1. Mood Stabilizers
12.4.2. Antipsychotics
12.4.3. Anti-depressants
12.4.4. Antianxiety Drugs
12.4.5. Others (Anticonvulsants, etc.)
  12.5. Market Attractiveness, by Drug Class
  12.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
12.6.1. Bipolar I Disorder
12.6.2. Bipolar II Disorder
12.6.3. Cyclothymic Disorder
12.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  12.7. Market Attractiveness, by Type of Bipolar Disorder
  12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals
12.8.2. Specialty Clinics
12.8.3. Mental Health Centers
12.8.4. Ambulatory Surgical Centers
  12.9. Market Attractiveness, by End-user
  12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
  12.11. Market Attractiveness Analysis
12.11.1. By Type of Treatment
12.11.2. By Drug Class
12.11.3. By Type of Bipolar Disorder
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Bipolar Disorder Treatment Market Analysis and Forecast
  13.1. Introduction
13.1.1. Key Findings
  13.2. Market Value Forecast, by Type of Treatment, 2020-2034
13.2.1. Pharmacotherapy
13.2.2. Psychotherapy
13.2.3. Electroconvulsive Therapy (ECT)
13.2.4. Transcranial Magnetic Stimulation (TMS)
13.2.5. Others (Hospitalization, etc.)
  13.3. Market Attractiveness, by Type of Treatment
  13.4. Market Value Forecast, by Drug Class, 2020-2034
13.4.1. Mood Stabilizers
13.4.2. Antipsychotics
13.4.3. Anti-depressants
13.4.4. Antianxiety Drugs
13.4.5. Others (Anticonvulsants, etc.)
  13.5. Market Attractiveness, by Drug Class
  13.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
13.6.1. Bipolar I Disorder
13.6.2. Bipolar II Disorder
13.6.3. Cyclothymic Disorder
13.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  13.7. Market Attractiveness, by Type of Bipolar Disorder
  13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals
13.8.2. Specialty Clinics
13.8.3. Mental Health Centers
13.8.4. Ambulatory Surgical Centers
  13.9. Market Attractiveness, by End-user
  13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
  13.11. Market Attractiveness Analysis
13.11.1. By Type of Treatment
13.11.2. By Drug Class
13.11.3. By Type of Bipolar Disorder
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Bipolar Disorder Treatment Market Analysis and Forecast
  14.1. Introduction
14.1.1. Key Findings
  14.2. Market Value Forecast, by Type of Treatment, 2020-2034
14.2.1. Pharmacotherapy
14.2.2. Psychotherapy
14.2.3. Electroconvulsive Therapy (ECT)
14.2.4. Transcranial Magnetic Stimulation (TMS)
14.2.5. Others (Hospitalization, etc.)
  14.3. Market Attractiveness, by Type of Treatment
  14.4. Market Value Forecast, by Drug Class, 2020-2034
14.4.1. Mood Stabilizers
14.4.2. Antipsychotics
14.4.3. Anti-depressants
14.4.4. Antianxiety Drugs
14.4.5. Others (Anticonvulsants, etc.)
  14.5. Market Attractiveness, by Drug Class
  14.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
14.6.1. Bipolar I Disorder
14.6.2. Bipolar II Disorder
14.6.3. Cyclothymic Disorder
14.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  14.7. Market Attractiveness, by Type of Bipolar Disorder
  14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals
14.8.2. Specialty Clinics
14.8.3. Mental Health Centers
14.8.4. Ambulatory Surgical Centers
  14.9. Market Attractiveness, by End-user
  14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
  14.11. Market Attractiveness Analysis
14.11.1. By Type of Treatment
14.11.2. By Drug Class
14.11.3. By Type of Bipolar Disorder
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Bipolar Disorder Treatment Market Analysis and Forecast
  15.1. Introduction
15.1.1. Key Findings
  15.2. Market Value Forecast, by Type of Treatment, 2020-2034
15.2.1. Pharmacotherapy
15.2.2. Psychotherapy
15.2.3. Electroconvulsive Therapy (ECT)
15.2.4. Transcranial Magnetic Stimulation (TMS)
15.2.5. Others (Hospitalization, etc.)
  15.3. Market Attractiveness, by Type of Treatment
  15.4. Market Value Forecast, by Drug Class, 2020-2034
15.4.1. Mood Stabilizers
15.4.2. Antipsychotics
15.4.3. Anti-depressants
15.4.4. Antianxiety Drugs
15.4.5. Others (Anticonvulsants, etc.)
  15.5. Market Attractiveness, by Drug Class
  15.6. Market Value Forecast, by Type of Bipolar Disorder, 2020-2034
15.6.1. Bipolar I Disorder
15.6.2. Bipolar II Disorder
15.6.3. Cyclothymic Disorder
15.6.4. Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
  15.7. Market Attractiveness, by Type of Bipolar Disorder
  15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals
15.8.2. Specialty Clinics
15.8.3. Mental Health Centers
15.8.4. Ambulatory Surgical Centers
  15.9. Market Attractiveness, by End-user
  15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
  15.11. Market Attractiveness Analysis
15.11.1. By Type of Treatment
15.11.2. By Drug Class
15.11.3. By Type of Bipolar Disorder
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
  16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  16.2. Market Share Analysis, by Company (2023)
  16.3. Company Profiles
16.3.1. Otsuka Pharmaceutical Co., Ltd.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. AstraZeneca plc
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. GSK plc
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Pfizer Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Eli Lilly and Company
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Johnson & Johnson
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. AbbVie Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Novartis AG
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Allergan plc
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Lundbeck A/S
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings